# Valar Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/valar-labs

- Industry: Healthcare IT
- Headquarters: Palo Alto, US
- Website: www.valarlabs.com
- Total disclosed funding: $26M
- Latest round: Series A (May 22, 2024)
- Investors on record: 3

## About

Established in 2021 and based in California, US, Valar Labs, Inc. operates as a provider of an (artificial intelligence) AI-based platform that primarily helps oncologists by answering clinical questions related to the patient’s characteristics. In May 2024, Valar Labs, Inc. raised USD 22 million in series A funding co-led by new investor Data Collective and returning investor Andreessen Horowitz, with participation from another returning investor Pear VC.

Valar Labs provides an AI-powered platform to assist oncologists in reimagining treatment decisions treatment for cancer patients. The company’s client base includes academic medical centers and community oncologists.

The company plans to use its proceeds from May 2024 funding to support its expansion and the development of its product called Vesta.

## Funding rounds

- Series A, May 22, 2024, $22M — Andreessen Horowitz, DCVC, Pear VC
- Seed, Dec 22, 2021, $4.2M — Andreessen Horowitz, Pear VC

## Investors

- Andreessen Horowitz (https://capitalatlas.ai/funds/andreessen-horowitz) — Seed, Series A
- Pear VC (https://capitalatlas.ai/funds/pear-vc) — Seed, Series A
- DCVC (https://capitalatlas.ai/funds/dcvc) — Series A